Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
4.160
-0.100 (-2.35%)
At close: Dec 20, 2024, 4:00 PM
4.200
+0.040 (0.96%)
After-hours: Dec 20, 2024, 6:56 PM EST
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $696.31 million as of December 20, 2024. Its market cap has decreased by -39.39% in one year.
Market Cap
696.31M
Enterprise Value
-93.48M
1-Year Change
-39.39%
Ranking
Category
Stock Price
$4.16
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $696.31M, a decrease of -77.06%. That is a compound annual growth rate of -28.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 696.31M | -48.69% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | 3.73B | 22.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ironwood Pharmaceuticals | 712.13M |
| Dianthus Therapeutics | 704.41M |
| Kura Oncology | 700.65M |
| Tectonic Therapeutic | 699.87M |
| Bioventus | 697.47M |
| Avanos Medical | 694.03M |
| IRADIMED CORPORATION | 692.60M |
| Keros Therapeutics | 689.84M |